Monte Rosa Therapeutics, Inc. (NASDAQ:GLUE) Sees Large Decline in Short Interest
Monte Rosa Therapeutics, Inc. (NASDAQ:GLUE – Get Free Report) was the recipient of a significant decrease in short interest in the month of March. As of March 15th, there was short interest totalling 7,030,000 shares, a decrease of 12.6% from the February 28th total of 8,040,000 shares. Based on an average daily trading volume, of […]
4 Apr 08:02 · The Markets Daily